Introduction
Diabetes is a national health priority. The Australian National Diabetes Strategy 2021–2030, released by the Australian Government in November 2021, has been developed in consultation with key stakeholders and people with diabetes.1 It outlines a ‘roadmap’ to address diabetes in Australia. Implementation of these priorities will impact primary care across a range of outcomes, along with the inevitable burden of rising numbers of people affected by diabetes and those at risk of developing this disease.
Almost 1.5 million Australians with diabetes have registered with the National Diabetes Services Scheme (NDSS), with more than 85% having type 2 diabetes.2 The number of people with type 2 diabetes is growing, most likely the result of rising overweight and obesity rates, lifestyle and dietary changes and an ageing population. If trends continue, the number of people in Australia diagnosed with diabetes may increase to 3.6 million by 2050.3
General practice plays a central role in the early identification and optimal management of people with type 2 diabetes, which can significantly reduce the risk of coronary artery disease, stroke, kidney failure, limb amputations and vision loss associated with the condition. General practice maintains a primary role from identifying those at risk, right through to caring for patients at the end of life. These guidelines give up-to-date, evidence-based information tailored for general practice to support general practitioners (GPs) and their teams in providing high-quality clinical management tools.
In developing the 2024 edition of Management of type 2 diabetes: A handbook for general practice, The Royal Australian College of General Practitioners (RACGP) has focused on factors relevant to current Australian clinical practice. The RACGP has used the skills and knowledge of your general practice peers who have an interest in diabetes management and are members of the RACGP Specific Interests Diabetes Network.
This publication has been produced in accordance with the rules and processes outlined in the RACGP’s conflicts of interest policy.
This edition represents 25 years of a successful relationship between the RACGP and Diabetes Australia. We acknowledge the support and contributions of the experts, writers, reviewers (listed under ‘Acknowledgements’) and RACGP staff in the development of these guidelines.